Different effects of the BIM deletion polymorphism on treatment of solid tumors by the tyrosine kinase inhibitors (TKI) pazopanib, sunitinib, and lapatinib.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Toby Johnson Chun-Fang Xu |
| Publication date | April 28, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |